June 6, 2018 Licensing, IP, and Legal M&A, Partnerships

Fujifilm Cellular Dynamics Announces Agreement with UCI to Commercialize iPSC-Derived Microglia and Media Formulation

Fujifilm Cellular Dynamics Announces Agreement with UCI to Commercialize iPSC-Derived Microglia and Media Formulation Usage of Cookies: Cookies are important to the proper functioning of this site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality and deliver content tailored to your interest.... Read more

June 4, 2018 Forensics & Security Licensing, IP, and Legal Life Science Tools

Ande Corporation’s Rapid DNA Identification System First to Receive FBI Approval Under New Standards

  Milestone marks major step toward use of Rapid DNA in police booking stations to dramatically reduce violent crime ANDE® Corporation today announced that its ANDE Rapid DNA™ Identification System has received National DNA Index System (NDIS) approval from the Federal Bureau of Investigation (FBI). The approval allows accredited NDIS laboratories to process DNA samples... Read more

May 8, 2018 Licensing, IP, and Legal

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore... Read more

May 8, 2018 Licensing, IP, and Legal Life Science Tools

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore... Read more

May 8, 2018 Licensing, IP, and Legal Life Science Tools

Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences

Wed 9th May 2018 Oxford Nanopore and Pacific Biosciences have agreed to discontinue UK and German litigation. In the settlement, Oxford Nanopore agreed not to sell its 2D kits in UK and Germany. 2D is, in any case, obsolete and was globally discontinued in May 2017, when Oxford Nanopore replaced it with the superior 1D^2... Read more

April 30, 2018 Licensing, IP, and Legal PR/Corporate

Xylem Inc. to Participate in the Oppenheimer 13th Annual Industrial Growth Conference

RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 30, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President, Continuous Improvement & Business Transformation Tony Milando and Sr. Director of Investor Relations Matt Latino will participate in group discussions at the Oppenheimer 13th... Read more